Sonen Capital’s Abiomed Inc ABMD Stock Holding History

Sonen Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,937	Closed	-$476K	–	103
2022 Q3	$476K	Sell	1,937 -553	-22%	-$149K	0.77%	56
2022 Q2	$616K	Sell	2,490 -565	-18%	-$152K	0.88%	42
2022 Q1	$1.01M	Buy	+3,055	New	+$940K	1.22%	25

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Sonen Capital's ABMD Position: Q4 2022 in Review

Sonen Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,937 shares — an estimated $476K sold.

Sonen Capital first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $1.01M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Sonen Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Sonen Capital sold 1,937 Abiomed Inc shares in Q4 2022, an estimated $476K.
Sonen Capital first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
Sonen Capital's Abiomed Inc position peaked at $1.01M in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Sonen Capital's 13F filing for Q4 2022, filed 7 Feb 2023.